Eszopiclone Contraindications
Eszopiclone has only one absolute contraindication: known hypersensitivity to eszopiclone, including prior anaphylaxis or angioedema. 1
Absolute Contraindication
- Known hypersensitivity to eszopiclone - This includes patients who have experienced anaphylaxis or angioedema (involving tongue, glottis, or larynx) after taking eszopiclone 1
- If angioedema occurs, do not rechallenge with the drug as airway obstruction can be fatal 1
Critical Warnings and Situations Requiring Extreme Caution
While not absolute contraindications, the following situations warrant either avoiding eszopiclone or using it only with extreme caution and dose reduction:
Severe Hepatic Insufficiency
- Requires dose reduction (though not an absolute contraindication) 2
- Start with 1 mg in elderly patients or those with hepatic impairment
High-Risk Scenarios for Serious Harm
Do not prescribe eszopiclone in patients who:
- Cannot commit to 7-8 hours of sleep time remaining (increased risk of next-day psychomotor impairment) 1
- Are concurrently using other sedative-hypnotics at bedtime 1
- Have a history of complex sleep behaviors (sleep-driving, sleep-walking with amnesia) on any hypnotic agent 1
Exercise extreme caution and consider alternatives in:
- Patients taking other CNS depressants (benzodiazepines, opioids, tricyclic antidepressants, alcohol) - requires downward dose adjustment of both agents 1
- Patients taking CYP3A4 inhibitors - increases eszopiclone blood levels 1
- Elderly patients with cognitive or motor impairments - higher risk of falls, fractures, and dementia 3
- Patients with uncontrolled psychiatric disorders - may worsen depression or cause suicidal ideation 1
Important Clinical Context
The FDA label emphasizes that eszopiclone is a CNS depressant that can impair daytime function even when used as prescribed, particularly at 2-3 mg doses 1. Patients using 3 mg must be cautioned against driving or hazardous activities the next day - this is not optional 1.
Common Pitfalls to Avoid
Prescribing without evaluating underlying causes - Sleep disturbances may indicate primary psychiatric or medical illness that requires evaluation before initiating hypnotics 1
Ignoring medication interactions - The combination with other CNS depressants significantly increases risk of cognitive/behavioral changes and complex sleep behaviors 1
Failing to use lowest effective dose - Adverse effects are dose-related; elderly patients should start at 1 mg 3, 1
Long-term prescribing without reassessment - If insomnia doesn't remit after 7-10 days, re-evaluate for primary psychiatric/medical illness 1
The American Academy of Sleep Medicine and American College of Physicians both provide weak recommendations for eszopiclone use, acknowledging efficacy but emphasizing that benefits are modest and long-term safety data remain limited 3, 4. Observational studies suggest hypnotic use associates with increased dementia, fractures, and major injury risk 3.